Professor of Medicine, Stanford University
Carnegie Centenary Professor 2016, University of Glasgow
Professor Cornelia Weyand is an outstanding clinician, scientist, teacher and leader in biomedical research and is internationally recognised as a world leader in immunity, inflammation and its direct contribution to vascular disease.
Professor Cornelia Weyand is the Chief of the Division of Immunology and Rheumatology at Stanford University School of Medicine. Professor Weyand previously directed the Clinical Immunology and Immunotherapeutics Program in the Department of Medicine at the Mayo Clinic and held the David C. Lowance Chair in Medicine at Emory University. She has had a special interest in tissue-damaging immune responses in rheumatoid arthritis, atherosclerosis and large vessel vasculitis. She has established several preclinical models, including a chimera model in which human synovial tissue and human blood vessels are engrafted into immunodeficient mice. In these model systems, Professor Weyand’s research team has defined the role of T cells and dendritic cells in deviating from protective to destructive immunity. Over the last decade, she has focused on how the immune system remodels with ageing, how chronic disease ages the immune system, and how aged immune cells cause inflammation. More recently she has worked on the role of the immune system in vascular inflammation, and has identified and characterized immune cells that mediate vasculitis and has thereby defined the molecular underpinnings of the immuno-stromal interactions that cause arterial inflammation. This seminal work has opened the field and there is now extensive research on the immune system, inflammation and vascular disease.